Phase 2 PME Clinical Trials
8 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–8 of 8 trials
Recruiting
Phase 2
The Impact of Shigellosis and Recommended Treatment in Children
ShigellaDiarrhea InfectiousGrowth & Development
Johns Hopkins Bloomberg School of Public Health700 enrolled4 locationsNCT07433426
Recruiting
Phase 1Phase 2
Gene Replacement Therapy for Treatment of Paediatric Patients With CTNNB1 Neurodevelopmental Syndrome
CTNNB1 Neurodevelopmental Syndrome
CTNNB1 Foundation12 enrolled1 locationNCT07270549
Recruiting
Phase 2
The Impact of a Virtual Magic Trick Training Program
AutismPervasive Developmental Disorder
University of Alabama at Birmingham60 enrolled1 locationNCT05664841
Not Yet Recruiting
Phase 2Phase 3
Effectiveness and safety of riluzole for the treatment of seizures in individuals with SCN8A developmental and epileptic encephalopathy (SCN8A-DEE).
SCN8A developmental and epileptic encephalopathy
University of Melbourne5 enrolled1 locationACTRN12625000845437
Recruiting
Phase 2
Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders
AnxietyTuberous SclerosisFragile X Syndrome+14 more
Holland Bloorview Kids Rehabilitation Hospital130 enrolled8 locationsNCT06081348
Recruiting
Phase 2Phase 3
Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior
HypoxiaNeurodevelopmental DisordersCongenital Heart Disease in Children+1 more
University of Utah150 enrolled5 locationsNCT05767385
Completed
Phase 2
Investigating the Lidcombe Program of early stuttering intervention for preschool age children when parental verbal contingencies for fluent and stuttered moments are removed.
Developmental stuttering in preschool children.
Australian Stuttering Research Centre, The University of Sydney82 enrolled1 locationACTRN12613001247763
Terminated
Phase 2
Deep repetitive transcranial magnetic stimulation for autism spectrum disorder
Pervasive developmental disorder - not otherwise specified
Dr. Peter Enticott80 enrolled1 locationACTRN12612001208897